Anoikis in cell fate, physiopathology, and therapeutic interventions
Jie Mei,
Xue‐Yao Jiang,
Hui‐Xiang Tian,
Ding‐Chao Rong,
Jia‐Nan Song,
Luozixian Wang,
Yuan‐Shen Chen,
Raymond C. B. Wong,
Cheng‐Xian Guo,
Lian‐Sheng Wang,
Lei‐Yun Wang,
Peng‐Yuan Wang,
Ji‐Ye Yin
Affiliations
Jie Mei
Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
Xue‐Yao Jiang
Oujiang Laboratory Key Laboratory of Alzheimer's Disease of Zhejiang Province Institute of Aging Wenzhou Medical University Wenzhou Zhejiang China
Hui‐Xiang Tian
Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
Ding‐Chao Rong
Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
Jia‐Nan Song
Oujiang Laboratory Key Laboratory of Alzheimer's Disease of Zhejiang Province Institute of Aging Wenzhou Medical University Wenzhou Zhejiang China
Luozixian Wang
Oujiang Laboratory Key Laboratory of Alzheimer's Disease of Zhejiang Province Institute of Aging Wenzhou Medical University Wenzhou Zhejiang China
Yuan‐Shen Chen
Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
Raymond C. B. Wong
Centre for Eye Research Australia Royal Victorian Eye and Ear Hospital Melbourne Victoria Australia
Cheng‐Xian Guo
Center of Clinical Pharmacology the Third Xiangya Hospital Central South University Changsha Hunan China
Lian‐Sheng Wang
Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
Lei‐Yun Wang
Department of Pharmacy Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Province China
Peng‐Yuan Wang
Oujiang Laboratory Key Laboratory of Alzheimer's Disease of Zhejiang Province Institute of Aging Wenzhou Medical University Wenzhou Zhejiang China
Ji‐Ye Yin
Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
Abstract The extracellular matrix (ECM) governs a wide spectrum of cellular fate processes, with a particular emphasis on anoikis, an integrin‐dependent form of cell death. Currently, anoikis is defined as an intrinsic apoptosis. In contrast to traditional apoptosis and necroptosis, integrin correlates ECM signaling with intracellular signaling cascades, describing the full process of anoikis. However, anoikis is frequently overlooked in physiological and pathological processes as well as traditional in vitro research models. In this review, we summarized the role of anoikis in physiological and pathological processes, spanning embryonic development, organ development, tissue repair, inflammatory responses, cardiovascular diseases, tumor metastasis, and so on. Similarly, in the realm of stem cell research focused on the functional evolution of cells, anoikis offers a potential solution to various challenges, including in vitro cell culture models, stem cell therapy, cell transplantation, and engineering applications, which are largely based on the regulation of cell fate by anoikis. More importantly, the regulatory mechanisms of anoikis based on molecular processes and ECM signaling will provide new strategies for therapeutic interventions (drug therapy and cell‐based therapy) in disease. In summary, this review provides a systematic elaboration of anoikis, thus shedding light on its future research.